Anthropic's IPO push includes a big bet on life sciences

Fecha de publicación: 31 de octubre de 2026, 10:10

Vas Narasimhan, CEO of the pharma giant Novartis, joined Anthropic's board of directors in April. Hollie Adams/Bloomberg via Getty Images Anthropic is starting to think like a drugmaker. Anthropic's IPO filing outlines its ambitious plans for biological science. AI in scientific research would aid…